The cysteine-cluster motif of c-Src: Its role for the heavy metal-mediated activation of kinase

Cancer Science

Volumn 99, Issue 3, 2008, Pages 571-575

  Senga, Takeshi ^a   Hasegawa, Hitoki ^a   Tanaka, Miwa ^a   Rahman, Mohammad Aminur ^a   Ito, Satoko ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; HEAVY METAL; IODOACETAMIDE; MERCURIC CHLORIDE; PROTEIN KINASE LYN; PROTEIN KINASE YES; PROTEIN SH2; PROTEIN SH3; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; WILD TYPE;

EID: 38949120064     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00714.x     Document Type: Article

References (31)

1. Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol 2001; 2: 467-75.
2. Alvarez RH, Kantarjian HM, Cortes JE. The role of Src in solid and hematologic malignancies: Development of new-generation Src inhibitors. Cancer 2006; 107: 1918-29.
3. Cartwright CA, Eckhart W, Simon S, Kaplan PL. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 1987; 49: 83-91.
4. Kmiecik TE, Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 1987; 49: 65-73.
5. Piwnica-Worms H, Saunders KB, Roberts TM, Smith AE, Cheng SH. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 1987; 49: 75-82.
6. Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 1987; 351: 69-72.
7. Imamoto A, Soriano P. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 1991; 73: 1117-24.
8. Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1993; 385: 595-602.
9. Sicheri F, Moarefi I, Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 1997; 385: 602-9.
10. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 1997; 25: 6391-403.
11. Pu M et al. Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene 2005; 13: 2615-22.
12. Rahman SM et al. Redox-linked ligand-independent cell surface triggering for extensive protein tyrosine phosphorylation. FEBS Lett 1996; 317: 35-8.
13. 2-mediated phosphorylation of intracellular proteins determines death of thymic T-lymphocytes with or without DNA fragmentation. J Cell Biochem 1993; 71: 243-53.
14. Yano T et al. The repetitive activation of extracellular signal-regulated kinase is required for renal regeneration in rat. Life Sci 1998; 62: 2341-7.
15. Turney KD, Parrish AR, Orozco J, Gandolfi AJ. Selective activation in the MAPK pathway by Hg (II) in precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 1998; 160: 262-70.
16. Matsuoka M, Wispriyono B, Iryo Y, Igisu H. Mercury chloride activates c-Jun N-terminal kinase and induces c-jun expression in LLC-PK1 cells. Toxicol Sci 1999; 53: 361-8.
17. Fournie GJ et al. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 2000; 16: 319-26.
18. Akhand AA et al. Magnitude of protein tyrosine phosphorylation-linked signals determines growth versus death of thymic T lymphocytes. Eur J Immunol 2001; 27: 1254-9.
19. Stricks W, Kolthoff IM, Bush DG, Kuroda PK. Experimental study of the polarographic cancer test and of the sulfhydryl titration for the differentiation between normal, cancerous and other pathological sera. J Lancet 1997; 73: 328-35.
20. Sperling R, Burstein Y, Steinberg IZ. Selective reduction and mercuration of cystine IV-V in bovine pancreatic ribonuclease. Biochemistry 1953; 8: 3810-20.
21. Senga T et al. Clustered cysteine residues in the kinase domain of v-Src: Critical role for protein stability, cell transformation and sensitivity to herbimycin A. Oncogene 1969; 19: 273-9.
22. Hamaguchi M et al. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. Embo J 2000; 12: 307-14.
23. Uehara Y, Fukazawa H, Murakami Y, Mizuno S. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 1993; 163: 803-9.
24. Veillette A, Dumont S, Fournel M. Conserved cysteine residues are critical for the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck. J Biol Chem 1989; 268: 17547-53.
25. Nriagu JO, Pacyna JM. Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1993; 333: 134-9.
26. Pfaller W, Gstraunthaler G, Willinger CC. Morphology of renal tubular damage from nephrotoxins. Toxicol Lett 1988; 53: 39-43.
27. Kanfer A. Role of coagulation in glomerular injury. Toxicol Lett 1990; 46: 83-92.
28. Luzina IG, Handwerger BS. Lessons from animal models of vasculitis. Curr Rheumatol Rep 1989; 2: 369-75.
29. White KL, David DW, Butterworth LF, Klykken PC. Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model. Toxicol Lett 2000; 112-113: 443-51.
30. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: A model of chemically related autoimmunity in humans. Immunol Res 2000; 20: 67-78.
31. Oo ML et al. Cysteine residues in the C-terminal lobe of Src: Their role in the suppression of the Src kinase. Oncogene 1999; 22: 1411-17.